|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reck M, Heigener DF, Mok T, Soria JC and
Rabe KF: Management of non-small-cell lung cancer: Recent
developments. Lancet. 382:709–719. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oliveira MB, Mello FC and Paschoal ME: The
relationship between lung cancer histology and the
clinicopathological characteristics of bone metastases. Lung
Cancer. 96:19–24. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Silva SC, Wilson C and Woll PJ:
Bone-targeted agents in the treatment of lung cancer. Ther Adv Med
Oncol. 7:219–228. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Michaelson MD and Smith MR:
Bisphosphonates for treatment and prevention of bone metastases. J
Clin Oncol. 23:8219–8224. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Renders GA, Vermeer JA, Leung PM, Reynaert
F, Prins C, Langenbach GE and Everts V: Implications of high-dosage
bisphosphonate treatment on bone tissue in the jaw and knee joint.
Calcif Tissue Int. 95:436–445. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ma NQ, Liu LL, Min J, Wang JW, Jiang WF,
Liu Y, Feng YG, Su HC, Feng YM and Zhang HL: The effect of down
regulation of calcineurin Aalpha by lentiviral vector-mediated RNAi
on the biological behavior of small-cell lung cancer and its bone
metastasis. Clin Exp Metastasis. 28:765–778. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pang H, Ma N, Shen W, Zhao Q, Wang J, Duan
L, Chen W, Zhang N, Zhao Z, Liu L, et al: Effects of DKK1
overexpression on bone metastasis of SBC-3 cells. Oncol Lett.
15:6739–6744. 2018.PubMed/NCBI
|
|
9
|
Pang H, Ma N, Jiao M, Shen W, Xin B, Wang
T, Zhang F, Liu L and Zhang H: The biological effects of Dickkopf1
on small cell lung cancer cells and bone metastasis. Oncol Res.
25:35–42. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma N, Shen W, Pang H, Zhang N, Shi H, Wang
J and Zhang H: The effect of RCAN1 on the biological behaviors of
small cell lung cancer. Tumor Biol. 39:10104283177004052017.
View Article : Google Scholar
|
|
11
|
Liu Y, Zhang Y, Min J, Liu LL, Ma NQ, Feng
YM, Liu D, Wang PZ, Huang DD, Zhuang Y, et al: Calcineurin promotes
proliferation, migration, and invasion of small cell lung cancer.
Tumor Biol. 31:199–207. 2010. View Article : Google Scholar
|
|
12
|
Ma N, Pang H, Shen W, Zhang F, Cui Z, Wang
J, Wang J, Liu L and Zhang H: Downregulation of CXCR4 by SDF-KDEL
in SBC-5 cells inhibits their migration in vitro and organ
metastasis in vivo. Int J Mol Med. 35:425–432. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y, Zhang N, Wang Y, Xu M, Liu N, Pang
X, Cao J, Ma N, Pang H, Liu L, et al: Zinc finger E-box binding
homeobox 1 promotes invasion and bone metastasis of small cell lung
cancerin vitro and in vivo. Cancer Sci. 103:1420–1428. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen W, Pang H, Xin B, Duan L, Liu L and
Zhang H: Biological effects of BMP7 on small-cell lung cancer cells
and its bone metastasis. Int J Oncol. 53:1354–1362. 2018.PubMed/NCBI
|
|
15
|
Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD
and Wang LH: Twist transcriptionally up-regulates AKT2 in breast
cancer cells leading to increased migration, invasion, and
resistance to paclitaxel. Cancer Res. 67:1979–1987. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Corre J, Hebraud B and Bourin P: Concise
review: Growth differentiation factor 15 in pathology: A clinical
role? Stem Cells Transl Med. 2:946–952. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li C, Wang X, Casal I, Wang J, Li P, Zhang
W, Xu E, Lai M and Zhang H: Growth differentiation factor 15 is a
promising diagnostic and prognostic biomarker in colorectal cancer.
J Cell Mol Med. 20:1420–1426. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu X, Chi X, Gong Q, Gao L, Niu Y, Chi X,
Cheng M, Si Y, Wang M, Zhong J, et al: Association of serum level
of growth differentiation factor 15 with liver cirrhosis and
hepatocellular carcinoma. PLoS One. 10:e1275182015.
|
|
20
|
Brown DA, Hance KW, Rogers CJ, Sansbury
LB, Albert PS, Murphy G, Laiyemo AO, Wang Z, Cross AJ, Schatzkin A,
et al: Serum macrophage inhibitory cytokine-1 (MIC-1/GDF15): A
potential screening tool for the prevention of colon cancer? Cancer
Epidem Biomar. 21:337–346. 2012. View Article : Google Scholar
|
|
21
|
Wollert KC, Kempf T and Wallentin L:
Growth differentiation factor 15 as a biomarker in cardiovascular
disease. Clin Chem. 63:140–151. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berezin AE: Diabetes mellitus related
biomarker: The predictive role of growth-differentiation factor-15.
Diabetes Metab Syndr 10 (1 Suppl 1):). S154–S157. 2016. View Article : Google Scholar
|
|
23
|
Osada M, Park HL, Park MJ, Liu JW, Wu G,
Trink B and Sidransky D: A p53-type response element in the
GDF15 promoter confers high specificity for p53 activation.
Biochem Biophys Res Commun. 354:913–918. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee SH, Krisanapun C and Baek SJ:
NSAID-activated gene-1 as a molecular target for capsaicin-induced
apoptosis through a novel molecular mechanism involving GSK3beta,
C/EBPbeta and ATF3. Carcinogenesis. 31:719–728. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baek SJ, Kim JS, Moore SM, Lee SH,
Martinez J and Eling TE: Cyclooxygenase inhibitors induce the
expression of the tumor suppressor gene EGR-1, which results in the
up-regulation of NAG-1, an antitumorigenic protein. Mol Pharmacol.
67:356–364. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang X, Baek SJ and Eling TE: The diverse
roles of nonsteroidal anti-inflammatory drug activated gene
(NAG-1/GDF15) in cancer. Biochem Pharmacol. 85:597–606. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zimmers TA, Gutierrez JC and Koniaris LG:
Loss of GDF-15 abolishes Sulindac chemoprevention in the
ApcMin/+ mouse model of intestinal cancer. J Cancer Res
Clin. 136:571–576. 2010. View Article : Google Scholar
|
|
28
|
Baek SJ, Okazaki R, Lee SH, Martinez J,
Kim JS, Yamaguchi K, Mishina Y, Martin DW, Shoieb A, McEntee MF and
Eling TE: Nonsteroidal anti-inflammatory drug-activated gene-1 over
expression in transgenic mice suppresses intestinal neoplasia.
Gastroenterology. 131:1553–1560. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Husaini Y, Qiu MR, Lockwood GP, Luo XW,
Shang P, Kuffner T, Tsai VW, Jiang L, Russell PJ, Brown DA and
Breit SN: Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows
cancer development but increases metastases in TRAMP prostate
cancer prone mice. PLoS One. 7:e438332012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arafat K, Iratni R, Takahashi T, Parekh K,
Al Dhaheri Y, Adrian TE and Attoub S: Inhibitory effects of
salinomycin on cell survival, colony growth, migration, and
invasion of human non-small cell lung cancer A549 and LNM35:
Involvement of NAG-1. PLoS One. 8:e669312013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cekanova M, Lee SH, Donnell RL,
Sukhthankar M, Eling TE, Fischer SM and Baek SJ: Nonsteroidal
anti-inflammatory drug-activated gene-1 expression inhibits
urethane-induced pulmonary tumorigenesis in transgenic mice. Cancer
Prev Res. 2:450–458. 2009. View Article : Google Scholar
|
|
32
|
Wang X, Yang Z, Tian H, Li Y, Li M, Zhao
W, Zhang C, Wang T, Liu J, Zhang A, et al: Circulating MIC-1/GDF15
is a complementary screening biomarker with CEA and correlates with
liver metastasis and poor survival in colorectal cancer.
Oncotarget. 8:24892–24901. 2017.PubMed/NCBI
|
|
33
|
Zhang Y, Hua W, Niu LC, Li SM, Wang YM,
Shang L, Zhang C, Li WN, Wang R, Chen BL, et al: Elevated growth
differentiation factor 15 expression predicts poor prognosis in
epithelial ovarian cancer patients. Tumor Biol. 37:84652016.
View Article : Google Scholar
|
|
34
|
Windrichova J, Fuchsova R, Kucera R,
Topolcan O, Fiala O, Finek J and Slipkova D: MIC1/GDF15 as a bone
metastatic disease biomarker. Anticancer Res. 37:1501–1506. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Westhrin M, Moen SH, Holien T, Mylin AK,
Heickendorff L, Olsen OE, Sundan A, Turesson I, Gimsing P, Waage A,
et al: Growth differentiation factor 15 (GDF15) promotes osteoclast
differentiation and inhibits osteoblast differentiation and high
serum GDF15 levels are associated with multiple myeloma bone
disease. Haematologica. 100:e511–e514. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wakchoure S, Swain TM, Hentunen TA,
Bauskin AR, Brown DA, Breit SN, Vuopala KS, Harris KW and Selander
KS: Expression of macrophage inhibitory cytokine-1 in prostate
cancer bone metastases induces osteoclast activation and weight
loss. Prostate. 69:652–661. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang Y, Jiang W, Wang L and Lingappan K:
Sex-specific differences in the modulation of growth
differentiation factor 15 (GDF15) by hyperoxia in vivo and in
vitro: Role of Hif-1α. Toxicol Appl Pharmacol. 332:8–14.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bertrand C, Kowalski-Chauvel A, Do C, Résa
C, Najib S, Daulhac L, Wang TC, Ferrand A and Seva C: A gastrin
precursor, gastrin-gly, upregulates VEGF expression in colonic
epithelial cells through an HIF-1-independent mechanism. Int J
Cancer. 126:2847–2857. 2010.PubMed/NCBI
|
|
39
|
Johnen H, Lin S, Kuffner T, Brown DA, Tsai
VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S, et al:
Tumor-induced anorexia and weight loss are mediated by the TGF-beta
superfamily cytokine MIC-1. Nat Med. 13:1333–1340. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Emmerson PJ, Wang F, Du Y, Liu Q, Pickard
RT, Gonciarz MD, Coskun T, Hamang MJ, Sindelar DK, Ballman KK, et
al: The metabolic effects of GDF15 are mediated by the orphan
receptor GFRAL. Nat Med. 23:1215–1219. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Vanhara P, Lincova E, Kozubik A, Jurdic P,
Soucek K and Smarda J: Growth/differentiation factor-15 inhibits
differentiation into osteoclasts-a novel factor involved in control
of osteoclast differentiation. Differentiation. 78:213–222. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Min K, Liggett JL, Silva G, Wu WW, Wang R,
Shen RF, Eling TE and Baek SJ: NAG-1/GDF15 accumulates in the
nucleus and modulates transcriptional regulation of the Smad
pathway. Oncogene. 35:377–388. 2016. View Article : Google Scholar : PubMed/NCBI
|
